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Abstract A 1 week preculture of endothelial or smooth muscle 
cells in glucose-enriched (11.2 to 44.8 raM) media resulted in a 
marked enhancement of the subsequent ability of cells to oxidize 
low density lipoprotein, as assessed by the lipid peroxidation end 
product and conjugated diene content of the particle, its relative 
electrophoretic mobility and its degradation by macrophages. 
This phenomenon is correlated to a marked stimulation of super- 
oxide anion secretion by cells. Such an effect of elevated glucose 
concentration on cell-induced LDL oxidative modification could 
be involved in the increased occurrence of atherosclerotic lesions 
in diabetes mellitus. 
Key words: LDL peroxidation; Glucose; Endothelial cell; 
Smooth muscle cell; Diabetes mellitus; Atherosclerosis 
phages. In the present work, we demonstrate that culture of 
endothelial or smooth muscle cells in glucose-enriched media 
results in increased ability of these cells to subsequently oxidize 
LDL, and that this phenomenon is accompanied by enhanced 
secretion of superoxide anion. 
2. Materials and methods 
2.1. Materials" 
Cell culture media and foetal calf serum were from Gibco, Grand 
Island, NY, USA. J774 murine macrophage-like c lls were from The 
American Type Culture Collection, Rockville, MD, USA. The UNA 
endothelial cells and A7r5 smooth muscle cells, both of murine origin, 
were generous gifts from Prof. J.D. Chapman (Fox Chase Cancer 
Institute, Philadelphia, USA) and Dr. O. Colard (Facult6 de M6decine 
Saint-Antoine, Paris, France), respectively. NalZSI (13-17 Ci/mg) was 
purchased from Amersham, Buckinghamshire, UK. 
1. Introduction 
Low density lipoprotein (LDL) peroxidation by endothelial 
cells, smooth muscle cells or monocytes i currently believed to 
be one of the main factors involved in the development of 
atherosclerotic lesions [1-4]. Oxidized LDL are less catabolized 
by the normal apo B/E receptor pathway, but are taken up by 
macrophages inducing cholesteryl ester accumulation and ap- 
pearance of foam cells, which contribute to the formation of 
atherosclerotic lesions [1-4]. 
During the last few years, an increasing number of studies 
have pointed out a possible role of LDL peroxidation in the 
occurrence of atherogenic lesions, which are one of the most 
frequent complications of diabetes mellitus [5-7]. The involve- 
ment of oxidative stress in diabetes is supported by several 
arguments uch as increased concentration of lipid peroxida- 
tion end products (thiobarbituric acid reactive substances: 
TBARS) and decreased content of antioxidants in the plasma 
of patients [8-10]. Recent studies have suggested that elevated 
glucose concentration i plasma could promote LDL oxidation 
by leading to glycated forms of the particle which are more 
sensitive to transition metal-dependent auto-oxidation [11]. 
Glucose by itself seems to enhance the in vitro LDL oxidative 
modification induced by copper ions [12,13]. However, there 
are at the present ime no studies on a possible ffect of elevated 
glucose concentration on the capacity of cultured cells to oxi- 
dize LDL, leading to modified forms being taken up by macro- 
*Corresponding author. 
Abbreviations: LDL, low density lipoprotein; TBARS, thiobarbituric 
acid reactive substance (lipid peroxidation end products). 
2.2. LDL preparation and labelling 
LDL (d = 1.024-1.050) was prepared from normal human serum by 
sequential ultracentrifugation according to Havel et al. [14], and 
dialyzed against 0.005 M Tris, 0.05 M NaC1, 0.02% EDTA, pH 7.4, for 
conservation. Prior to oxidation, EDTA was removed by dialysis for 
24 h, and LDL stored at 4°C before oxidation by cultured cells within 
2 days. ~25I labelling of LDL was performed by the method escribed 
by Bilheimer et al. [15]. The specific activity was about 250 cprn/ng. 
2.3. Cell culture 
UNA endothelial cells were cultured in Ham's FI0 medium, and 
A7r5 smooth muscle cells in Dulbecco's modified minimum essential 
medium, both supplemented with 10% foetal calf serum. The J774 
macrophage cell line was maintained in suspension in RPMI 1640 
medium supplemented with 10% heat inactivated foetal calf serum. For 
LDL degradation determination, the cells were seeded in 3.5 cm Petri 
dishes (2 x 10 6 cells/dish). All experiments were performed on subcon- 
fluent cultures. 
2.4. LDL oxidation 
Cells were precultured for 1 week in serum supplemented medium in 
the presence of increasing (5.6 to 44.8 mM) concentrations of glucose. 
LDL (0.1 mg/ml LDL protein) were then incubated for 24 h with cells 
in standard Ham's F10 medium without further addition of glucose. 
The TBARS content of LDL was checked by the ftuorometric assay of 
Yagi [16]. Results are expressed in nmol equivalent malondialdehyde/ 
mg LDL protein, using malondialdehyde from tetramethoxypropane 
as a standard, and calculated as % of control. Conjugated ienes were 
measured at 234 nm as previously described [17]. The modification of 
the negative net charge of LDL was assessed by agarose gel-electro- 
phoresis at pH 8.6 in a Ciba Coming system. 
2.5. LDL degradation by J774 macrophage-like c lls 
Oxidation of [~25I]LDL by cells was first carried out with 0.02 pg/ml 
LDL as previously described [18]. The medium was then transferred to 
J774 cells. LDL degradation was determined after 6 h as the trichlo- 
roacetic acid-soluble non-iodide radioactivity, and expressed in ng LDL 
degraded/rag cellular protein. Blank values from parallel incubations 
without cells were also determined. 
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Fig. 1. Effect of glucose on LDL oxidative modification by endothelial or smooth muscle cells. Cells were precultured for I week in medium containing 
increasing (5.6 to 44.8 mM) concentrations of glucose, washed, and then incubated for 24 h with 0.1 mg/ml LDL in standard Ham's F10 medium, 
The degree of LDL modification was assessed by the TBARS (a) or conjugated dienes (b) content of the particle, and by measurement of its relative 
electrophoretic mobility (c). Triangles, UNA endothelial cells; circles, A7r5 smooth muscle cells. 100% for the LDL TBARS contents were 44 _+ 6 
and 36 + 4 nmol/mg LDL protein for UNA and A7r5 cells, respectively. 100% for conjugated ienes, expressed as the differential OD at 234 nm 
were 0.25 + 0.03 and 0.20 + 0.02 for UNA and A7r5 cells, respectively. Means of 6 experimental values + S.D. 
2.6. Secretion of superoxide anion by cells 
Cells were cultured for 1 week in medium supplemented with differ- 
ent concentrations of glucose. After washing, the cells were then incu- 
bated for 1 h in Dulbecco's modified minimum essential medium devoid 
of Phenol red, in the presence of 2.10 -5 M horse heart cytochrome  
[19]. Superoxide anion release was calculated from the difference in OD 
at 550 nm in the absence and presence of superoxide dismutase (100 
¢tg/ml), using a molar extinction coefficient of 21/mM/cm. 
Each experiment was performed at least 3 times in duplicate. Statis- 
tical analysis was performed by Student's t-test. 
3. Results 
Fig. 1 displays the effect of a 1 week preculture in medium 
containing increasing lucose concentrations, on the ability of 
endothelial or smooth muscle cells to subsequently oxidize 
LDL. It can be clearly observed that the 3 parameters tested 
for checking LDL oxidation (TBARS content, conjugated 
diene formation, and relative electrophoretic mobility of the 
particle) were increased in a dose-dependent manner with the 
glucose concentration in the culture medium. A 35-45% in- 
crease in TBARS content and diene formation was observed 
at the highest tested glucose concentration (44.8 raM); under 
the same culture conditions, the relative electrophoretic mobil- 
ity of the particle was increased by about 30% as compared 
to LDL oxidized by cells cultured in control (5.6 mM) me- 
dium. 
Since oxidized LDL is rapidly taken up by the scavenger 
pathway of macrophages, we also studied the degradation of 
the labelled particle by J774 monocyte macrophages. Table I 
shows that LDL degradation was augmented after modifica- 
tion by cells cultured in glucose-enriched medium, with an 
about 65 and 50% increase for endothelial and smooth muscle 
cells exposed to 44.8 mM glucose, respectively. 
As active oxygen species have been suggested to be involved 
in LDL oxidative modification [20,21], we then measured the 
influence of glucose on superoxide anion secretion by UNA or 
A7r5 cells. Table 2 shows that superoxide production was 
markedly and dose-dependently stimulated by a 1 week precul- 
ture in glucose-enriched medium, with an about 1.5 or 2 fold 
increase for glucose concentrations of 22.4 or 44.8 mM, respec- 
tively. 
4. Discussion 
The above results clearly show that preculture of endothelial 
or smooth muscle cells in glucose-enriched medium induced a 
dose-dependent increase in LDL oxidative modification and 
recognition by macrophages, the latter process being currently 
believed to be one of the important steps involved in the initia- 
tion and progression of atherogenic lesions. 
It is now believed that LDL modification is involved in the 
pathogenesis of atherosclerotic lesions, which occur with in- 
creased frequency in patients with diabetes mellitus. Although 
a lot of studies have been concerned with the role of non- 
enzymatic LDL glycosylation in the atherosclerotic complica- 
tions of diabetes [22 24], only a few have focused attention on 
Table 1 
Degradation by J774 monocyte macrophages of LDL modified by 
endothelial or smooth muscle cells precultured in glucose-enriched me- 
dium 
[~25I]LDL degradation (ng/mg protein) 
Endothelial cells Smooth muscle cells 
LDL without cells, 
125 + 18 








437 + 49 345 ___ 39 
552 + 67* 380 _+ 46 
628 + 55** 448 + 52* 
715 + 82*** 490 + 62** 
790 + 95*** 527 _+ 75*** 
UNA endothelial cells or A7r5 smooth muscle cells were precultured 
for 1 week in medium supplemented with various glucose concentra- 
tions, then washed 3 times and incubated for 24 h with 0.02 mg/ml 
[125I]LDL in standard Ham's FI0 medium. [~25I]LDL degradation was 
then studied as previously described. Results are expressed as ng 
[~25I]LDL degraded/rag cell protein. Means of 6 experimental val- 
ues + S.D. *P < 0.05; **P < 0.01; ***P < 0.001 by Student's t-test. 
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Table 2 
Effect of glucose on superoxide anion release by endothelial and 
smooth muscle cells 
Glucose (g/l) Superoxide release (nmol/h/mg protein) 
Endothelial cells Smooth muscle cells 
5.6 (control) 134 + 12 102 + 18 
11.2 172 +_ 21" 124 _+ 15 
22.4 215 + 38** 145 + 18" 
33.6 256 _+ 33*** 163 + 22** 
44.8 270 + 42*** 176 + 19"** 
UNA endothelial cells or A7r5 smooth muscle cells were precultured 
for 1 week in medium containing 5.6 to 44.8 mM glucose before deter- 
mination of the superoxide anion release. Means of 6 experimental 
values + S.D. *P < 0.05; **P < 0.01; ***P < 0.001 by Student's t-test. 
a possible involvement of LDL lipid peroxidation i  this proc- 
ess. In particular, it has recently been shown that high glucose 
concentrations enhance in vitro LDL auto-oxidation i duced 
by copper ions [12,13]. Glycated LDL also seems to be more 
sensitive to copper-induced oxidative modification [11]. In all 
these studies, attention has mainly been paid to the direct influ- 
ence of high glucose concentrations or of LDL glycation on the 
oxidisability of the particle in in vitro models (LDL auto-oxida- 
tion). However, it might also be supposed that elevated glucose 
concentrations in the blood of patients with diabetes mellitus 
results in an alteration in the metabolism of the cells involved 
in LDL oxidative modification, such as endothelial nd smooth 
muscle cells. To our knowledge, the present work is the first 
demonstration of a stimulatory effect of glucose on cell-medi- 
ated oxidative modification of LDL. Similar results were ob- 
tained with U937 monocyte-like cells (data not shown), which 
are also widely used as an experimental model for studying 
LDL modification. 
It must be stressed that in our experimental system, LDL 
modification by cells was conducted in the absence of added 
glucose (standard Ham's F10 medium containing 5.6 mM glu- 
cose), which eliminated the possibility of a direct effect of glu- 
cose on the oxidative process. It is also noteworthy that a 
significant enhancement of cell-mediated LDL modification 
was already observed at 22.4 mM of glucose, a concentration 
which is much lower than that used in most of the studies 
dealing with LDL glycation [11,22]. Moreover, only a 1 week 
culture of cells in glucose-enriched medium is sufficient o ob- 
serve a significant effect. A longer pretreatment period (24  
weeks) did not led to a proportional increase in the ability of 
cells to modify LDL (data not shown). Our studies also demon- 
strate for the first time that the production (or/and secretion) 
of superoxide anion by endothelial or smooth muscle cells is 
increased by a preculture in glucose-enriched media. It is note- 
worthy that under experimental conditions, up to 44.8 raM, no 
significant effect of glucose was noted on cell proliferation as 
assessed by cell counting or by [3H]thymidine incorporation 
into DNA. Regardless of the mechanisms, which remain to be 
specified, the observation that elevated glucose concentrations 
in the culture medium enhances superoxide production and the 
subsequent ability of endothelial and smooth muscle cells to 
oxidatively modify LDL brings a new insight o the pathogene- 
sis of atherosclerotic lesions in diabetes mellitus. 
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